GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Debt-to-Asset

Aroa Biosurgery (ASX:ARX) Debt-to-Asset : 0.07 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Debt-to-Asset?

Aroa Biosurgery's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was A$0.92 Mil. Aroa Biosurgery's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was A$5.90 Mil. Aroa Biosurgery's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was A$101.88 Mil. Aroa Biosurgery's debt to asset for the quarter that ended in Mar. 2024 was 0.07.

Aroa Biosurgery Debt-to-Asset Historical Data

The historical data trend for Aroa Biosurgery's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Debt-to-Asset Chart

Aroa Biosurgery Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Asset
0.18 0.20 0.05 0.06 0.07

Aroa Biosurgery Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Debt-to-Asset Get a 7-Day Free Trial 0.05 0.05 0.06 0.06 0.07

Competitive Comparison of Aroa Biosurgery's Debt-to-Asset

For the Medical Devices subindustry, Aroa Biosurgery's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aroa Biosurgery's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aroa Biosurgery's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Aroa Biosurgery's Debt-to-Asset falls into.


Aroa Biosurgery Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Aroa Biosurgery's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.921 + 5.899) / 101.878
=0.07

Aroa Biosurgery's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.921 + 5.899) / 101.878
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aroa Biosurgery  (ASX:ARX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Aroa Biosurgery Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Aroa Biosurgery (ASX:ARX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Debt-to-Asset
Comparable Companies
ASX:IPD ASX:AVR ASX:CYC ASX:4DX ASX:EMV ASX:IMR ASX:MX1 ASX:SOM ASX:UBI ASX:NTI ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Website
https://www.aroabio.com
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines